In COVID-19 patients, high serum levels of IL-12 and IL-18 have been described [2,40], further supporting the idea that MAIT cell decline in peripheral blood in COVID-19 patients may, at least partly, result from chronic cytokine exposure in vivo. The gene discussed is IL18; the disease is COVID-19.